<DOC>
	<DOCNO>NCT00490243</DOCNO>
	<brief_summary>The present study conduct determine effect four week treatment budesonide , montelukast , budesonide montelukast budesonide formoterol child atopic asthma lung function : forced expiratory volume one second , mid-expiratory flow , peak expiratory flow rate , resistance interrupter technique , plethysmographic specific airway resistance , exercise-induced bronchial hyperreactivity clinical symptom .</brief_summary>
	<brief_title>Effect Different Anti-Asthmatic Treatments Lung Function Exercise-Induced Bronchoconstriction Children With Asthma</brief_title>
	<detailed_description>Asthma one common chronic disease worldwide , impose substantial social burden child . Allergic inflammation responsible clinical symptom asthma . The effect allergic inflammation : bronchial muscle constriction , excessive mucus production , edema mucosa , element „ asthmatic triad ” cause bronchial obturation . Normal lung function one goal asthma management . In study effect monotherapy symptom score , lung function parameter bronchial hyperreactivity assess . The present study conduct determine effect four week treatment budesonide , montelukast , budesonide montelukast budesonide formoterol child atopic asthma lung function : forced expiratory volume one second , mid-expiratory flow , peak expiratory flow rate , resistance interrupter technique , plethysmographic specific airway resistance , exercise-induced bronchial hyperreactivity clinical symptom .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Anti-Asthmatic Agents</mesh_term>
	<criteria>Male female outpatient Aged 6 18 clinical diagnosis bronchial asthma duration least 6 month first visit current history moderate persistent asthma Sensitive house dust mites show positive skinprick test Dermatophagoides pteronyssinus Dermatophagoides farinae To become eligible active treatment period , patient parent require reproducible spirometry , whole body plethysmography interrupter technique . In order include study patient rest FEV1 equal 70 % . Study exclusion include : Active upper respiratory tract infection within 3 week study acute sinus disease require antibiotic treatment within 1 month study Previous intubation Asthma hospitalisation 3 month first visit . Additional criterion clinically significant pulmonary , hematologic , hepatic , gastrointestinal , renal , endocrine , neurologic , cardiovascular , and/or psychiatric disease malignancy either put patient risk participate study could influence result study patient 's ability participate study judge investigator . Excluded medication βblockers ( eye drop include ) , astemizole within 3 month , oral corticosteroid within 1 month first visit . Patients receive immunotherapy also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Children</keyword>
	<keyword>Exercise</keyword>
	<keyword>Pulmonary Function</keyword>
	<keyword>Budesonide</keyword>
	<keyword>Montelukast</keyword>
	<keyword>Formoterol</keyword>
</DOC>